Literature DB >> 29167031

Vaccination coverage in patients affected by chronic diseases: A 2014 cross-sectional study among subjects hospitalized at Bari Policlinico General Hospital.

Maria Serena Gallone1, Vittoria Infantino1, Davide Ferorelli2, Pasquale Stefanizzi1, Sara De Nitto1, Silvio Tafuri3.   

Abstract

Subjects affected by at least 1 chronic disease are the target of influenza vaccination strategies because they are at high risk of influenza complications or death. The aim of this cross-sectional study is to evaluate flu and pneumococcal vaccination coverage (VC) in a sample of patients hospitalized at Bari Policlinico General Hospital (South Italy). According to national public health guidelines, these patients should have been vaccinated at hospital discharge by general practitioners. There were 540 patients involved in the study, and the average age was of 46.9 ± 13.4 years (range, 0-64 years). We assessed the vaccination status of 412 of 540 (76.3%) patients. The overall VC was 22.8% (94/412) for influenza and 7.2% (30/412) for pneumococcal vaccine. Doctor recommendation has a pivotal importance in vaccine acceptance, and recent experiences seem to show a high efficacy of the vaccination offer during hospitalization. This model could be helpful to improve influenza and pneumococcal vaccination offers to patient with underlying chronic conditions.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Influenza; chronic-degenerative diseases; vaccine

Mesh:

Substances:

Year:  2017        PMID: 29167031     DOI: 10.1016/j.ajic.2017.10.004

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  3 in total

1.  Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups.

Authors:  Lise Boey; Eline Bosmans; Liane Braz Ferreira; Nathalie Heyvaert; Melissa Nelen; Lisa Smans; Hanne Tuerlinckx; Mathieu Roelants; Kathleen Claes; Inge Derdelinckx; Wim Janssens; Chantal Mathieu; Johan Van Cleemput; Robin Vos; Corinne Vandermeulen
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

2.  In-hospital and web-based intervention to counteract vaccine hesitancy in very preterm infants' families: a NICU experience.

Authors:  Antonio Di Mauro; Federica Di Mauro; Chiara Greco; Orazio Valerio Giannico; Francesca Maria Grosso; Maria Elisabetta Baldassarre; Manuela Capozza; Federico Schettini; Pasquale Stefanizzi; Nicola Laforgia
Journal:  Ital J Pediatr       Date:  2021-09-16       Impact factor: 2.638

3.  Vaccination coverage among paediatric onco-haematological patients: an Italian cross-sectional study.

Authors:  Paola Giordano; Nicola Santoro; Pasquale Stefanizzi; Stefano Termite; Sara De Nitto; Francesco Paolo Bianchi; Paola Carmela Corallo; Giuseppe Lassandro; Silvio Tafuri
Journal:  Hum Vaccin Immunother       Date:  2020-08-26       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.